CLINICAL TRIALS PROFILE FOR DUPHALAC
✉ Email this page to a colleague
All Clinical Trials for DUPHALAC
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00745147 ↗ | Comparison of TCM and Laxatives for Adults With Chronic Constipation | Completed | National Taiwan University Hospital | Phase 3 | 2008-07-01 | The purpose of the study is to compare the therapeutic efficacy, safety, cost-effectiveness and maintenance effect between Chinese herbal formula and lactulose on chronic constipation in long-term care. |
| NCT01008293 ↗ | Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life | Completed | All India Institute of Medical Sciences, New Delhi | Phase 2/Phase 3 | 2009-10-01 | This study is a randomized, open, parallel group, active comparator, single center trial. Objectives of the study are hereby given below: - To study the health related quality of life (HRQOL) in patients with chronic liver disease. - To assess the prevalence of minimal hepatic encephalopathy (MHE) in patients with chronic liver disease and assessment of HRQOL in patients with MHE. - To compare the effect of probiotics and lactulose in the treatment of MHE - To assess the effect of probiotics and lactulose on the HRQOL in patients with MHE. |
| NCT01008293 ↗ | Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life | Completed | Indian Council of Medical Research | Phase 2/Phase 3 | 2009-10-01 | This study is a randomized, open, parallel group, active comparator, single center trial. Objectives of the study are hereby given below: - To study the health related quality of life (HRQOL) in patients with chronic liver disease. - To assess the prevalence of minimal hepatic encephalopathy (MHE) in patients with chronic liver disease and assessment of HRQOL in patients with MHE. - To compare the effect of probiotics and lactulose in the treatment of MHE - To assess the effect of probiotics and lactulose on the HRQOL in patients with MHE. |
| NCT01008293 ↗ | Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life | Completed | CD Pharma India Pvt. Ltd. | Phase 2/Phase 3 | 2009-10-01 | This study is a randomized, open, parallel group, active comparator, single center trial. Objectives of the study are hereby given below: - To study the health related quality of life (HRQOL) in patients with chronic liver disease. - To assess the prevalence of minimal hepatic encephalopathy (MHE) in patients with chronic liver disease and assessment of HRQOL in patients with MHE. - To compare the effect of probiotics and lactulose in the treatment of MHE - To assess the effect of probiotics and lactulose on the HRQOL in patients with MHE. |
| NCT04787276 ↗ | Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy | Completed | Bogomolets National Medical University | N/A | 2017-01-10 | The purpose of study to assess the short-term efficacy and safety of probiotic E.coli Nissle 1917 strain comparing to lactulose and rifaximin in patients with mild (Stage 1-2) or minimal hepatic encephalopathy |
| NCT05134584 ↗ | Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders | Recruiting | RenJi Hospital | Phase 4 | 2021-08-01 | Our study aims to assess the efficacy and safety of linaclotide in patients with overlapping symptoms of both functional dyspepsia (FD) and constipation-predominant irritable bowel syndrome (IBS-C). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DUPHALAC
Condition Name
Clinical Trial Locations for DUPHALAC
Clinical Trial Progress for DUPHALAC
Clinical Trial Phase
Clinical Trial Sponsors for DUPHALAC
Sponsor Name
